Provided by Tiger Trade Technology Pte. Ltd.

Belite Bio, Inc.

155.04
+4.212.79%
Volume:126.81K
Turnover:19.77M
Market Cap:6.10B
PE:-67.00
High:159.45
Open:153.00
Low:153.00
Close:150.83
52wk High:200.00
52wk Low:49.00
Shares:39.34M
Float Shares:18.76M
Volume Ratio:0.81
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3141
EPS(LYR):-2.3141
ROE:-16.94%
ROA:-11.29%
PB:7.92
PE(LYR):-67.00

Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 02

Belite Bio Inc expected to post a loss of 55 cents a share - Earnings Preview

Reuters
·
Feb 28

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 27

Belite Bio Inc. to Host Webcast on Preliminary Fourth-Quarter and Full-Year Financial Results

Reuters
·
Feb 23

Belite Bio (BLTE) Valuation Check As Phase 3 DRAGON Tinlarebant Data Presentations Approach

Simply Wall St.
·
Feb 02

Belite Bio Showcases Phase 3 Tinlarebant Results at Asia-Pacific Academy of Ophthalmology Congress

Reuters
·
Jan 29

Belite Bio Price Target Maintained With a $185.00/Share by HC Wainwright & Co.

Dow Jones
·
Jan 28

U.S. RESEARCH ROUNDUP- Boeing, Carvana, UnitedHealth

Reuters
·
Jan 28

H.C. Wainwright Remains a Buy on Belite Bio, Inc. ADR (BLTE)

TIPRANKS
·
Jan 28

Belite Bio Completes Enrollment in the Dragon Ii Clinical Trial of Tinlarebant for Stargardt Disease (Stgd1)

THOMSON REUTERS
·
Jan 27

Belite Bio Inc - to File Nda With FDA in 1H 2026

THOMSON REUTERS
·
Jan 27

Belite Bio Completes Enrollment in the DRAGON II Clinical Trial of Tinlarebant for Stargardt Disease (STGD1)

GlobeNewswire
·
Jan 27

BUZZ-U.S. STOCKS ON THE MOVE-Apple, Belite Bio, Bank of Marin Bancorp

Reuters
·
Jan 27

BUZZ-Belite Bio climbs as BofA starts coverage with 'buy' rating

Reuters
·
Jan 26

BofA Securities Initiates Coverage on Belite Bio With Buy Rating, $195 Price Target

MT Newswires Live
·
Jan 26

Belite Bio Inc : Bofa Global Research Initiates Coverage With Buy Rating and Price Objective $195.00

THOMSON REUTERS
·
Jan 26

Belite Bio Initiated at Buy by B of A Securities

Dow Jones
·
Jan 26

U.S. RESEARCH ROUNDUP-CACI International, First Citizens Bancshares, Teledyne Technologies

Reuters
·
Jan 26

Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Arrowhead Pharmaceuticals (ARWR) and Alector (ALEC)

TIPRANKS
·
Jan 21

Belite Bio Initiated at Overweight by Morgan Stanley

Dow Jones
·
Jan 06